Fibroblast growth factor-21 enhances mitochondrial functions and increases the activity of PGC-1α in human dopaminergic neurons via Sirtuin-1

SpringerPlus

Volumn 3, Issue 1, 2014, Pages

  Mäkelä, Johanna ^a,b   Tselykh, Timofey V ^a,b   Maiorana, Francesca ^a,c   Eriksson, Ove ^a   Do, Hai Thi ^a,b   Mudò, Giuseppa ^c   Korhonen, Laura T ^a,b   Belluardo, Natale ^c   Lindholm, Dan ^a,b  

^a UNIVERSITY OF HELSINKI   (Finland)

^b MINERVA FOUNDATION INSTITUTE FOR MEDICAL RESEARCH   (Finland)

^c UNIVERSITY OF PALERMO   (Italy)

Author keywords

Dopaminergic neurons; FGF21; Mitochondria; Parkinson's disease; PGC 1 ; SIRT1

Indexed keywords

EID: 84892539497     PISSN: None     EISSN: 21931801     Source Type: Journal    
DOI: 10.1186/2193-1801-3-2     Document Type: Article

References (60)

1. Abou-Sleiman PM, Muqit MM, Wood NW (2006) Expanding insights of mitochondrial dysfunction in Parkinson's disease. Nat Rev Neurosci 7(3):207-219
2. Alcaín FJ, Villalba JM (2009) Sirtuin activators. Expert Opin Ther Pat 19(4):403-414. Doi: 10.1517/13543770902762893
3. Banerjee R, Starkov AA, Beal MF, Thomas B (2009) Mitochondrial dysfunction in the limelight of Parkinson's disease pathogenesis. Biochim Biophys Acta 1792(7):651-663. Doi: 10.1016/j.bbadis.2008.11.007
4. Belluardo N, Wu G, Mudo G, Hansson AC, Pettersson R, Fuxe K (1997) Comparative localization of fibroblast growth factor receptor-1,-2, and-3 mRNAs in the rat brain: in situ hybridization analysis. J Comp Neurol 379(2):226-246. 57
5. Chau MD, Gao J, Yang Q, Wu Z, Gromada J (2010) Fibroblast growth factor 21 regulates energy metabolism by activating the AMPK-SIRT1-PGC-1α pathway. Proc Natl Acad Sci U S A 107(28):12553-12558. Doi: 10.1073/pnas.1006962107
6. Cui L, Jeong H, Borovecki F, Parkhurst CN, Tanese N, Krainc D (2006) Transcriptional repression of PGC-1α by mutant huntingtin leads to mitochondrial dysfunction and neurodegeneration. Cell 127(1):59-69
7. Di Liberto V, Mäkelä J, Korhonen L, Olivieri M, Tselykh T, Mälkiä A, Do Thi H, Belluardo N, Lindholm D, Mudò G (2012) Involvement of estrogen receptors in the resveratrolmediated increase in dopamine transporter in human dopaminergic neurons and in striatum of female mice. Neuropharmacology 62(2):1011-1018. Doi: 10.1016/j.neuropharm.2011.10.010
8. Do HT, Tselykh TV, Makela J, Ho TH, Olkkonen VM, Bornhauser BC, Korhonen L, Zelcer N, Lindholm D (2012) Fibroblast growth factor-21 (FGF21) regulates low-density lipoprotein receptor (LDLR) levels in cells via the E3-ubiquitin ligase Mylip/Idol and the Canopy2 (Cnpy2)/Mylip-interacting saposin-like protein (Msap). J Biol Chem 287(16):12602-12611. Doi: 10.1074/jbc.M112.341248
9. Fisher FM, Kleiner S, Douris N, Fox EC, Mepani RJ, Verdeguer F, Wu J, Kharitonenkov A, Flier JS, Maratos-Flier E, Spiegelman BM (2012) FGF21 regulates PGC-1α and browning of white adipose tissues in adaptive thermogenesis. Genes Dev 26(3):271-281. Doi: 10.1101/gad.177857.11
10. Garten A, Petzold S, Körner A, Imai S, Kiess W (2009) Nampt: linking NAD biology, metabolism and cancer. Trends Endocrinol Metab 20(3):130-138. Doi: 10.1016/j.tem.2008.10.004
11. Gerhart-Hines Z, Rodgers JT, Bare O, Lerin C, Kim SH, Mostoslavsky R, Alt FW, Wu Z, Puigserver P (2007) Metabolic control of muscle mitochondrial function and fatty acid oxidation through SIRT1/PGC-1α. EMBO J 26(7):1913-1923
12. Gupta A, Dawson VL, Dawson TM (2008) What causes cell death in Parkinson's disease? Ann Neurol 64(Suppl 2):S3-S15
13. Handschin C, Spiegelman BM (2006) Peroxisome proliferator-activated receptor γ coactivator 1 coactivators, energy homeostasis, and metabolism. Endocr Rev 27(7):728-735
14. Henchcliffe C, Beal MF (2008) Mitochondrial biology and oxidative stress in Parkinson disease pathogenesis. Nat Clin Pract Neurol 4(11):600-609. Doi: 10.1038/ncpneuro0924
15. Houten SM, Auwerx J (2004) PGC-1α: turbocharging mitochondria. Cell 119(1):5-7
16. Hsuchou H, Pan W, Kastin AJ (2007) The fasting polypeptide FGF21 can enter brain from blood. Peptides 28(12):2382-2386
17. Hyrskyluoto A, Pulli I, Törnqvist K, Ho TH, Korhonen L, Lindholm D (2013) Sigma-1 receptor agonist PRE084 is protective against mutant huntingtin-induced cell degeneration: involvement of calpastatin and the NF-κB pathway. Cell Death Dis 4:e646. Doi: 10.1038/cddis.2013.17
18. Inagaki T, Dutchak P, Zhao G, Ding X, Gautron L, Parameswara V, Li Y, Goetz R, Mohammadi M, Esser V, Elmquist JK, Gerard RD, Burgess SC, Hammer RE, Mangelsdorf DJ, Kliewer SA (2007) Endocrine regulation of the fasting response by PPARα-mediated induction of fibroblast growth factor 21. Cell Metab 5(6):415-425
19. Itoh N, Ornitz DM (2011) Fibroblast growth factors: from molecular evolution to roles in development, metabolism and disease. J Biochem 149(2):121-130. Doi: 10.1093/jb/mvq121
20. Jenner P, Olanow CW (2006) The pathogenesis of cell death in Parkinson's disease. Neurology 66(10 Suppl 4):S24-S36
21. Kairisalo M, Korhonen L, Sepp M, Pruunsild P, Kukkonen JP, Timmusk T, Blomgren K, Lindholm D (2009) NF-κB-dependent regulation of Brain-derived Neurotrophic factor in hippocampal neurons by X-linked Inhibitor of Apoptosis Protein. Eur J Neurosci 30(6):958-966. Doi: 10.1111/j.1460-9568.2009.06898.x
22. Kairisalo M, Bonomo A, Hyrskyluoto A, Mudo G, Belluardo N, Korhonen L, Lindholm D (2011) Resveratrol reduces oxidative stress and cell death and increases mitochondrial antioxidants and XIAP in PC6.3-cells. Neurosci Lett 488(3):263-266. Doi: 10.1016/j.neulet.2010.11.042
23. Kharitonenkov A, Shiyanova TL, Koester A, Ford AM, Micanovic R, Galbreath EJ, Sandusky GE, Hammond LJ, Moyers JS, Owens RA, Gromada J, Brozinick JT, Hawkins ED, Wroblewski VJ, Li DS, Mehrbod F, Jaskunas SR, Shanafelt AB (2005) FGF-21 as a novel metabolic regulator. J Clin Invest 115(6):1627-1630
24. Kharitonenkov A, Dunbar JD, Bina HA, Bright S, Moyers JS, Zhang C, Ding L, Micanovic R, Mehrbod SF, Knierman MD, Hale JE, Coskun T, Shanafelt AB (2008) FGF-21/FGF-21 receptor interaction and activation is determined by β-Klotho. J Cell Physiol 215(1):1-7
25. Kim D, Nguyen MD, Dobbin MM, Fischer A, Sananbenesi F, Rodgers JT, Delalle I, Baur JA, Sui G, Armour SM, Puigserver P, Sinclair DA, Tsai LH (2007) SIRT1 deacetylase protects against neurodegeneration in models for Alzheimer's disease and amyotrophic lateral sclerosis. EMBO J 26(13):3169-3179
26. Kleiner S, Mepani RJ, Laznik D, Ye L, Jurczak MJ, Jornayvaz FR, Estall JL, Chatterjee Bhowmick D, Shulman GI, Spiegelman BM (2012) Development of insulin resistance in mice lacking PGC-1α in adipose tissues. Proc Natl Acad Sci U S A 109(24):9635-9640. Doi: 10.1073/pnas.1207287109
27. Korhonen L, Belluardo N, Lindholm D (2001) Regulation of X-chromosome-linked inhibitor of apoptosis protein in kainic acid-induced neuronal death in the rat hippocampus. Mol Cell Neurosci 17(2):364-372
28. Korhonen L, Hansson I, Maugras C, Wehrle R, Kairisalo M, Borgkvist A, Jokitalo E, Sotelo G, Fisone G, Dusart I, Lindholm D (2008) Expression of XIAP in mature Purkinje cells and in retinal bipolar cells in transgenic mice induces neurodegeneration. Neuroscience 156(3):515-526. Doi: 10.1016/j.neuroscience.2008.08.005
29. Lagouge M, Argmann C, Gerhart-Hines Z, Meziane H, Lerin C, Daussin F, Messadeq N, Milne J, Lambert P, Elliott P, Geny B, Laakso M, Puigserver P, Auwerx J (2006) Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1α. Cell 127(6):1109-1122
30. Lahti L, Peltopuro P, Piepponen TP, Partanen J (2012) Cell-autonomous FGF signaling regulates anteroposterior patterning and neuronal differentiation in the mesodiencephalic dopaminergic progenitor domain. Development 139(5):894-905. Doi: 10.1242/dev.071936
31. Lees AJ, Hardy J, Revesz T (2009) Parkinson's disease. Lancet 373(9680):2055-2066. Doi: 10.1016/S0140-6736(09)60492-X
32. Lin MT, Beal MF (2006) Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases. Nature 443(7113):787-795
33. Lin J, Handschin C, Spiegelman BM (2005) Metabolic control through the PGC-1 family of transcription coactivators. Cell Metab 1(6):361-370
34. Lindholm D, Castrén E, Kiefer R, Zafra F, Thoenen H (1992) Transforming growth factor-β 1 in the rat brain: increase after injury and inhibition of astrocyte proliferation. J Cell Biol 117(2):395-400
35. Lindholm D, Eriksson O, Korhonen L (2004) Mitochondrial proteins in neuronal degeneration. Biochem Biophys Res Commun 321(4):753-758
36. Lindholm D, Eriksson O, Mäkelä J, Belluardo N, Korhonen L (2012) PGC-1α: a master gene that is hard to master. Cell Mol Life Sci 69(15):2465-2468. Doi: 10.1007/s00018-012-1043-0
37. Lotharius J, Barg S, Wiekop P, Lundberg C, Raymon HK, Brundin P (2002) Effect of mutant α-synuclein on dopamine homeostasis in a new human mesencephalic cell line. J Biol Chem 277(41):38884-38894
38. Mäkelä J, Koivuniemi R, Korhonen L, Lindholm D (2010) Interferon-γ produced by microglia and the neuropeptide PACAP have opposite effects on the viability of neural progenitor cells. PLoS One 5(6):e11091. Doi: 10.1371/journal.pone.0011091
39. Mercken EM, Hu J, Krzysik-Walker S, Wei M, Li Y, McBurney MW, De Cabo R, Longo VD (2013) SIRT1 but not its increased expression is essential for lifespan extension in caloric restricted mice. Aging Cell. Doi: 10.1111/acel.1215
40. Mudò G, Bonomo A, Di Liberto V, Frinchi M, Fuxe K, Belluardo N (2009) The FGF- 2/FGFRs neurotrophic system promotes neurogenesis in the adult brain. J Neural Transm 116(8):995-1005. Doi: 10.1007/s00702-009-0207-z
41. Mudo G, Makela J, Di Liberto V, Tselykh TV, Olivieri M, Piepponen P, Eriksson O, Malkia A, Bonomo A, Kairisalo M, Aguirre JA, Korhonen L, Belluardo N, Lindholm D (2012) Transgenic expression and activation of PGC-1α protect dopaminergic neurons in the MPTP mouse model of Parkinson's disease. Cell Mol Life Sci 69(7):1153-1165. Doi: 10.1007/s00018-011-0850-z
42. Nemoto S, Fergusson MM, Finkel T (2005) SIRT1 functionally interacts with the metabolic regulator and transcriptional coactivator PGC-1α. J Biol Chem 280(16):16456-16460
43. Nishimura T, Nakatake Y, Konishi M, Itoh N (2000) Identification of a novel FGF, FGF-21, preferentially expressed in the liver. Biochim Biophys Acta 1492(1):203-206
44. Nunnari J, Suomalainen A (2012) Mitochondria: in sickness and in health. Cell 148(6):1145-1159. Doi: 10.1016/j.cell.2012.02.035
45. Outeiro TF, Marques O, Kazantsev A (2008) Therapeutic role of sirtuins in neurodegenerative disease. Biochim Biophys Acta 1782(6):363-369. Doi: 10.1016/j.bbadis.2008.02.010
46. Patrone C, Eriksson O, Lindholm D (2013) Diabetes drugs and neurological disorders: new views and therapeutic possibilities: the lancet diabetes & endocrinology. Early Online Publication. Doi: 10.1016/S2213-8587(13)70125-6
47. Potthoff MJ, Inagaki T, Satapati S, Ding X, He T, Goetz R, Mohammadi M, Finck BN, Mangelsdorf DJ, Kliewer SA, Burgess SC (2009) FGF21 induces PGC-1α and regulates carbohydrate and fatty acid metabolism during the adaptive starvation response. Proc Natl Acad Sci U S A 106(26):10853-10858. Doi: 10.1073/pnas.0904187106
48. Revollo JR, Grimm AA, Imai S (2004) The NAD biosynthesis pathway mediated by nicotinamide phosphoribosyltransferase regulates Sir2 activity in mammalian cells. J Biol Chem 279(49):50754-50763
49. Rodgers JT, Puigserver P (2007) Fasting-dependent glucose and lipid metabolic response through hepatic sirtuin 1. Proc Natl Acad Sci U S A 104(31):12861-12866
50. Sokka AL, Putkonen N, Mudo G, Pryazhnikov E, Reijonen S, Khiroug L, Belluardo N, Lindholm D, Korhonen L (2007) Endoplasmic reticulum stress inhibition protects against excitotoxic neuronal injury in the rat brain. J Neurosci 27(4):901-908
51. St-Pierre J, Drori S, Uldry M, Silvaggi JM, Rhee J, Jager S, Handschin C, Zheng K, Lin J, Yang W, Simon DK, Bachoo R, Spiegelman BM (2006) Suppression of reactive oxygen species and neurodegeneration by the PGC-1 transcriptional coactivators. Cell 127(2):397-408
52. Suzuki M, Uehara Y, Motomura-Matsuzaka K, Oki J, Koyama Y, Kimura M, Asada M, Komi-Kuramochi A, Oka S, Imamura T (2008) β-Klotho is required for fibroblast growth factor (FGF) 21 signaling through FGF receptor (FGFR) 1c and FGFR3c. Mol Endocrinol 22(4):1006-1014. Doi: 10.1210/me.2007-0313
53. Tomiyama K, Maeda R, Urakawa I, Yamazaki Y, Tanaka T, Ito S, Nabeshima Y, Tomita T, Odori S, Hosoda K, Nakao K, Imura A, Nabeshima Y (2010) Relevant use of Klotho in FGF19 subfamily signaling system in vivo. Proc Natl Acad Sci U S A 107(4):1666-1671. Doi: 10.1073/pnas.0913986107
54. Wang T, Zhang X, Bheda P, Revollo JR, Imai S, Wolberger C (2006) Structure of Nampt/PBEF/visfatin, a mammalian NAD + biosynthetic enzyme. Nat Struct Mol Biol 13(7):661-662
55. Wu Z, Puigserver P, Andersson U, Zhang C, Adelmant G, Mootha V, Troy A, Cinti S, Lowell B, Scarpulla RC, Spiegelman BM (1999) Mechanisms controlling mitochondrial biogenesis and respiration through the thermogenic coactivator PGC-1. Cell 98(1):115-124
56. Xie H, Lev D, Gong Y, Wang S, Pollock RE, Wu X, Gu J (2013) Reduced mitochondrial DNA copy number in peripheral blood leukocytes increases the risk of soft tissue sarcoma. Carcinogenesis 34(5):1039-1043. Doi: 10.1093/carcin/bgt023
57. Yang H, Lavu S, Sinclair DA (2006) Nampt/PBEF/Visfatin: a regulator of mammalian health and longevity? Exp Gerontol 41(8):718-726
58. Zhang Y, Xie Y, Berglund ED, Coate KC, He TT, Katafuchi T, Xiao G, Potthoff MJ, Wei W, Wan Y, Yu RT, Evans RM, Kliewer SA, Mangelsdorf DJ (2012) The starvation hormone, fibroblast growth factor-21, extends lifespan in mice. Elife 1:e00065. Doi: 10.7554/eLife.00065
59. Zheng B, Liao Z, Locascio JJ, Lesniak KA, Roderick SS, Watt ML, Eklund AC, Zhang- James Y, Kim PD, Hauser MA, Grunblatt E, Moran LB, Mandel SA, Riederer P, Miller RM, Federoff HJ, Wullner U, Papapetropoulos S, Youdim MB, Cantuti-Castelvetri I, Young AB, Vance JM, Davis RL, Hedreen JC, Adler CH, Beach TG, Graeber MB, Middleton FA, Rochet JC, Scherzer CR (2010) PGC-1α, a potential therapeutic target for early intervention in Parkinson's disease. Sci Transl Med 2(52):52ra73. Doi: 10.1126/scitranslmed.3001059
60. Zhou C, Huang Y, Przedborski S (2008) Oxidative stress in Parkinson's disease: a mechanism of pathogenic and therapeutic significance. Ann N Y Acad Sci 1147:93-104. Doi: 10.1196/annals.1427.023